Global market valuation was derived through revenue mapping and unit shipment analysis. The methodology included:
Identification of 50+ key manufacturers across North America, Europe, Asia-Pacific, and Latin America
Product mapping across therapeutic robots, assistive robots, exoskeletons, and telepresence robots categories
Analysis of reported and modeled annual revenues specific to rehabilitation robotics portfolios
Coverage of manufacturers representing 75-80% of global market share in 2024
Extrapolation using bottom-up (unit shipments × ASP by country/region) and top-down (manufacturer revenue validation) approaches to derive segment-specific valuations across robot type, application, operation mode, patient demographics, and end-user segments
This methodology aligns with the specific segments identified in the report: Robot Type (Therapeutic Robots, Assistive Robots, Exoskeletons, Telepresence Robots), Application (Physical Rehabilitation, Neurological Rehabilitation, Orthopedic Rehabilitation, Geriatric Rehabilitation), Operation Mode (Fully Autonomous, Semi-Autonomous, Teleoperated), Patient Demographics (Pediatric, Adult, Geriatric), and End User (Hospitals, Rehabilitation Centers, Home Care Settings).